| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 06/03/1999 | WO1999026583A2 Inhibtion of lipoprotein oxidation |
| 06/03/1999 | CA2303864A1 Inhibition of lipoprotein oxidation |
| 06/02/1999 | EP0918759A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 05/26/1999 | EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
| 05/26/1999 | EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
| 05/20/1999 | WO1999023879A1 Method for the augmentation of gene expression |
| 05/20/1999 | CA2310575A1 Method for the augmentation of gene expression |
| 05/19/1999 | EP0916337A2 Use of inhibitors of the sodium-hydrogen exchange in the manufacture of amedicament for reducing unwanted effects of compounds on the heart. |
| 05/19/1999 | EP0915843A1 Azetidinone derivatives for the treatment of atheroscleroses |
| 05/19/1999 | CN1216701A New use of sinomenine |
| 05/18/1999 | US5904921 Stabilized compositions of superoxide dismutase obtained from germinated plant seeds |
| 05/14/1999 | WO1999023097A1 Substituted porphyrins |
| 05/12/1999 | EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/12/1999 | EP0914118A1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 05/12/1999 | EP0914094A1 Materials and methods for making improved liposome compositions |
| 05/12/1999 | CN1216220A Heatstroke preventing tea |
| 05/05/1999 | CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 04/29/1999 | WO1999020264A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 04/29/1999 | WO1999020242A1 Compositions based on plant extracts |
| 04/29/1999 | CA2306414A1 Compositions based on plant extracts |
| 04/28/1999 | EP0910360A1 Reduction of cardiotoxicity of an antitumor agent using manganese compound |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1214869A Dongling (Rabdosia rubescens) coffee and its preparation method |
| 04/22/1999 | WO1999018961A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 04/22/1999 | WO1999018949A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | CA2306096A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | CA2304374A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 04/14/1999 | EP0907318A1 Antioxidant compound |
| 04/14/1999 | EP0584285B1 Treatment of schizophrenia by cholinesterase inhibitors |
| 04/08/1999 | WO1999016468A1 Antigen vectors in the form of multilamellar vesicles |
| 04/08/1999 | WO1999016422A1 Stabilized preparations for use in metered dose inhalers |
| 04/08/1999 | WO1999016421A1 Stabilized bioactive preparations and methods of use |
| 04/08/1999 | WO1999016420A1 Stabilized preparations for use in nebulizers |
| 04/08/1999 | WO1999016419A1 Perforated microparticles and methods of use |
| 04/08/1999 | CA2304824A1 Antigen vectors in the form of multilamellar vesicles and compositions containing antigens encapsulated in these vesicles |
| 04/07/1999 | EP0906090A1 Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/07/1999 | EP0717737B1 Chelants as contrast enhancing agents |
| 04/07/1999 | EP0697882A4 Use of glutathione diesters |
| 04/07/1999 | CN1213311A Method of using emu oil and active peactions thereof as insect repellant |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213300A Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/06/1999 | US5891856 Nonmutating cells by treatment with metabolites and aminoalkylphosphorothioate |
| 04/06/1999 | US5891457 Treating menorrhagia with silver nitrate composition |
| 04/01/1999 | WO1999015894A2 Method of identification of leads or active compounds |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999002564A3 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 04/01/1999 | CA2304783A1 Method of identification of leads or active compounds |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 03/31/1999 | EP0905512A1 Method of identification of leads or active compounds |
| 03/31/1999 | EP0904110A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 03/31/1999 | CN1212163A Smoking health-care product |
| 03/30/1999 | US5889037 Prevention, therapy tissue damage from lipid peroxidation |
| 03/23/1999 | US5886003 Administering 5-ht2 antagonists |
| 03/23/1999 | US5885959 Cyclic peptide compounds and their production process |
| 03/23/1999 | US5885548 Diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 for use as contrast media and antidotes |
| 03/18/1999 | WO1999012891A1 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 03/18/1999 | WO1998058635A3 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis |
| 03/17/1999 | EP0901469A1 Arylalkylpiperazine compounds as antioxidants |
| 03/17/1999 | CN1211190A Natural tea for taking off the effects of drink and process for production thereof |
| 03/17/1999 | CN1210730A Plant preparation and its preparing method |
| 03/16/1999 | US5882944 Methods for G protein coupled receptor activity screening |
| 03/11/1999 | WO1999011278A1 Robinia pseudoacacia lectin and its uses |
| 03/11/1999 | WO1999011264A1 Il-8 receptor antagonists |
| 03/11/1999 | WO1999011253A1 Il-8 receptor antagonists |
| 03/11/1999 | DE19738604A1 Use of Na<+>/H<+> exchange inhibitors |
| 03/11/1999 | CA2302450A1 Il-8 receptor antagonists |
| 03/11/1999 | CA2302364A1 Il-8 receptor antagonists |
| 03/11/1999 | CA2301848A1 Robinia pseudoacacia lectin and its uses |
| 03/10/1999 | EP0900781A2 Phenolic acid amides of hydroxy substituted benzylamines |
| 03/10/1999 | EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 03/10/1999 | CN1209995A The use of inhibitors of sodium-hydrogen exchanger for production of medicaement for decreaing undesired effects of substances on heart |
| 03/04/1999 | CA2246633A1 The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart |
| 03/03/1999 | EP0898559A2 Cytoprotective compounds |
| 03/03/1999 | EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 03/03/1999 | EP0627909B1 Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract |
| 03/03/1999 | CN1209802A Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
| 03/03/1999 | CN1209751A Improved concentrated injection and infusion solutions for intravenous administration |
| 03/02/1999 | US5877274 Antimicrobial cationic peptides |
| 03/02/1999 | US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/1999 | US5877172 Process for isolating galanthamine |
| 03/02/1999 | US5876916 Administration of glycerol-pyruvate or hydroxyacetone pyruvate ester with biocompatible carrier to mammals; as high calorie food, anticholesterol agents, antiishemic agents, organ preservative, antidiabetic agents |
| 03/02/1999 | US5876727 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/18/1999 | WO1998051348A3 Sustained-release delayed gels |
| 02/16/1999 | US5872119 2-Naphthamide derivatives and their therapeutic applications |
| 02/16/1999 | US5871724 Administering to the subject an amount of a transforming growth factor beta 3 effective to slow the growth of normal cells |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | CN1207309A Process for preparation of Rhus verniciflus extract and anti-cancer composition containing same |
| 02/10/1999 | CN1207300A Medicine for giving up drug |
| 02/09/1999 | US5869456 Use of glutathione diesters |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/03/1999 | CN1206594A Process for preparing antidote of Soman intoxication |
| 02/03/1999 | CN1041925C (S)-(+)-5-amino-2,4,6,7-tetramethyl-2-(4-phenyl piperidyl)-2,3-dihydrobenzo (6) furan crystal and use |
| 02/02/1999 | US5866122 Using prothrombinase |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002479A1 Method for producing calcium pyruvates |